Steven Hood

Steven Hood currently serves as an Analyst at Bios Partners, a venture capital firm dedicated to investments across the biotechnology and life sciences sectors. In this capacity, he is responsible for evaluating early-stage healthcare opportunities, conducting rigorous scientific due diligence, and supporting ongoing portfolio management initiatives. His operational scope requires bridging the gap between complex scientific innovation and financial viability to guide institutional investment decisions within the broader medical landscape. Hood actively participates in comprehensive deal sourcing across the global biotechnology ecosystem, identifying emerging therapeutics and medical technologies that align with the firm's strategic mandate. By analyzing market trends and clinical data, he provides critical analytical support to the partnership team during the entire transaction execution process. His current focus remains centered on deploying venture capital into high-growth life sciences enterprises to advance novel healthcare solutions.